Search
for

    Sort by

    Research 31–60 of 1000+

    1. MP31-04 HOW DO 5-ALPHA-REDUCTASE INHIBITORS CHANGE PSA DENSITY IN PATIENTS ON ACTIVE SURVEILLANCE? 2024
    2. Gleason grading controversies: what the chemoprevention trials have taught us Canadian Urological Association Journal · 2013 · 4 citations
    3. 5ARIs and PSA: Evidences Urologia Journal · 2014 · 3 citations
    4. S4 URETHRAL PSA LEVELS AFTER RADICAL PROSTATECTOMY European Urology Supplements · 2010
    5. Clinical effects and economical impact of dutasteride and finasteride therapy in Italian men with LUTS Archivio italiano di urologia, andrologia · 2013 · 4 citations
    6. 1450 THE TRUE BENEFIT OF PSA-SCREENING: MODELING THE IMPACT OF TRIAL SETTING AND PROTOCOL ON MORTALITY The Journal of Urology · 2012
    7. Editorial Comment Urology · 2009
    8. Finasteride, To Take, or Not to Take 2010
    9. Επικύρωση της χρησιμότητας των νεότερων παραμέτρων του PSA ορού για την ανίχνευση του καρκίνου του προστάτη 2018
    10. Editorial Comment Urology · 2013
    11. This Month in Adult Urology 2018
    12. Acneiform eruptions caused by an epidermal growth factor receptor-tyrosine kinase inhibitor ZD 1839 Journal of the American Academy of Dermatology · 2004 · 1 citations
    13. A comparison of self-reported signs of facial aging among women in Australia vs. those in the United States, United Kingdom, and Canada Journal of The American Academy of Dermatology · 2017
    14. This Month in Clinical Urology The Journal of Urology · 1999
    15. Telogen effluvium on the unilateral flank with testicular tumor in a dog Jui rinsho hifuka · 2019
    16. Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case–control series of veterans Cancer Causes & Control · 2013 · 12 citations
    17. The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention 2011 · 147 citations
    18. Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer Communications biology · 2020 · 113 citations
    19. THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction? Dermatologic Therapy · 2010 · 9 citations
    20. Prostate Carcinoma, what would be the best to do ? International Journal of Clinical and Medical Education Research · 2023
    21. S5 IS THE RADICAL PROSTATECTOMY THE BEST CHOICE FOR PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER? European Urology Supplements · 2010
    22. Association between degrees of alopecia and prostate specific antigen level in men with androgenetic alopecia Journal of The American Academy of Dermatology · 2019
    23. Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial British Journal of Cancer · 2009 · 49 citations
    24. Androgen Receptor Polymorphism-Dependent Variation in Prostate-Specific Antigen Concentrations of European Men Cancer Epidemiology, Biomarkers & Prevention · 2014 · 9 citations
    25. Prostate cancer update: 2007 Current Opinion in Oncology · 2008 · 6 citations
    26. Dutasteride: A Review of its Use in the Management of Prostate Disorders Clinical medicine insights · 2011 · 2 citations
    27. Prostate cancer update: 2007 Current Opinion in Internal Medicine · 2008
    28. Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss? Nature Clinical Practice Urology · 2007
    29. Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes SPIRE - Sciences Po Institutional REpository · 2023
    30. Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers The Prostate · 2017 · 7 citations